Picture of Idox logo

IDOX Idox News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyConservativeSmall CapHigh Flyer

REG - IDOX PLC - Exercise of Share Options & Total Voting Rights





 




RNS Number : 2860A
IDOX PLC
10 September 2018
 

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

 

Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 50,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares"), pursuant to an exercise of options under its share option plan.

Application has been made for the 50,000, new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 13 September 2018.

The total number of Ordinary Shares in issue following Admission will be 416,908,167. The Company holds 1,491,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 415,416,948.

The above figure of 415,416,948 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

 

Enquiries:

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

 

 

 

 

 

N+1 Singer (NOMAD and Broker)

+44 (0) 20 7496 3000

Shaun Dobson

 

Jen Boorer

 

 

 

MHP (Financial PR)

+44 (0) 20 3128 8100

Reg Hoare

 

 

Charlie Barker

 

 

       

 

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRBBLFFVKFLBBL

Recent news on Idox

See all news